SIEMENS HEALTH ADR/050 (SHL1) — Cash Flow Reinvestment Rate
SIEMENS HEALTH ADR/050 (SHL1) has a Cash Flow Reinvestment Rate of 0.33x as of December 2025, reinvesting €163.00 Million (capex €161.00 Million plus investments €2.00 Million) from operating cash flow of €492.00 Million. Check SHL1 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
SIEMENS HEALTH ADR/050 Cash Flow Reinvestment Rate (2022–2024)
Historical reinvestment intensity for SIEMENS HEALTH ADR/050 across 3 annual periods. Explore debt repayment capacity of SIEMENS HEALTH ADR/050 to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for SIEMENS HEALTH ADR/050 (2022–2024)
Year-by-year capital reinvestment analysis for SIEMENS HEALTH ADR/050. For live market cap and broader valuation context, see SHL1 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | €772.00 Million | €2.83 Billion | €696.00 Million | ▼ -31.3% |
| 2023 | 0.40x | €843.00 Million | €2.12 Billion | €838.00 Million | ▲ +14.9% |
| 2022 | 0.35x | €867.00 Million | €2.50 Billion | €852.00 Million | — |